IDERA PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENT December 8, 2006Stock Purchase Agreement • May 4th, 2010 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Stock Purchase Agreement (this “Agreement”) is entered into as of the date set forth above by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Merck & Co., Inc., a New Jersey corporation (“Merck”). The parties hereby agree as follows:
AMENDMENT NO. 2 TO THE CONSULTING SERVICES AGREEMENTConsulting Agreement • May 4th, 2010 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Amendment No. 2, effective the 15th day of December, 2009, (“Amendment No. 2 Date”) is by and between Idera Pharmaceuticals, Inc., a Delaware corporation, having a place of business at 167 Sidney Street, Cambridge, Massachusetts 02139 (hereinafter referred to as “Idera”) and Karr Pharma Consulting, LLC, having a place of business at 707 Dominion Drive, St. Louis, Missouri 63131 (hereinafter referred to as the “Consultant”). Idera and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”
CONSULTING AGREEMENTConsulting Agreement • May 4th, 2010 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS CONSULTING AGREEMENT (the “Agreement”), made this 1st day of April, 2010 (“Effective Date”) is entered into by Idera Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 167 Sidney Street, Cambridge, MA 02139 (the “Company”), and Malcolm MacCoss, Ph.D., an individual being a Member of Bohicket Pharma Consulting LLC and having a place of residence located 2556 Seabrook Island Road, Seabrook Island, SC 29455 (the “Consultant”). Company and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”
